help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, C. D.
Right arrow Articles by Baxter, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, C. D.
Right arrow Articles by Baxter, R. C.

Endocrinology, Vol 116, 1094-1101, Copyright © 1985 by Endocrine Society


ARTICLES

Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture

CD Scott, JL Martin and RC Baxter

This study examines the production and characteristics of insulin-like growth factor I (IGF I) and its binding protein (BP) from adult rat hepatocytes in primary culture. IGF I and BP in samples of conditioned medium were separated by automated high pressure gel permeation chromatography at pH 2.8, with total recovery of both species. Measured by a specific RIA, with about 2% IGF II cross-reactivity, the rate of production of IGF I [compared with a human IGF I (hIGF I) standard] was 4.39 +/- 0.57 pmol/mg cell protein X 24 h; measured by a radioligand assay using radioiodinated hIGF I as tracer, BP was produced at a rate of 2.97 +/- 0.54 pmol binding sites/mg cell protein X 24 h. High pressure permeation chromatography studies indicated approximate mol wts of 7,500 for hepatocyte IGF I and 50,000 for BP. The pI of hepatocyte IGF I was 8.8, and of the predominant BP species, 6.8. Rat serum treated in the same way as hepatocyte medium showed IGF I and BP activities at identical pI values to those from hepatocytes but, in addition, contained BP activity at more acidic pI values, apparently not produced directly by the liver. Competitive binding studies using acid-chromatographed hepatocyte or serum BP, and hIGF I and IGF II as labeled and unlabeled ligands, also suggested that BP activity in serum was heterogeneous, while BP from hepatocytes appeared to be a single species with similar affinities for IGF I and IGF II. It is concluded that adult rat hepatocytes produce immunoreactive IGF I, pI 8.8, and BP, pI 6.8, which are released into the circulation, but that additional, more acidic, BP species which are also found in serum could result from extrahepatic production or processing.


This article has been cited by other articles:


Home page
EndocrinologyHome page
J.-G. Scharf, F. Dombrowski, R. Novosyadlyy, C. Eisenbach, I. Demori, B. Kubler, and T. Braulke
Insulin-Like Growth Factor (IGF)-Binding Protein-1 Is Highly Induced during Acute Carbon Tetrachloride Liver Injury and Potentiates the IGF-I-Stimulated Activation of Rat Hepatic Stellate Cells
Endocrinology, July 1, 2004; 145(7): 3463 - 3472.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
J-G Scharf, F Dombrowski, and G Ramadori
The IGF axis and hepatocarcinogenesis
Mol. Pathol., June 1, 2001; 54(3): 138 - 144.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. B. Solerte, M. Fioravanti, G. Vignati, A. Giustina, L. Cravello, and E. Ferrari
Dehydroepiandrosterone Sulfate Enhances Natural Killer Cell Cytotoxicity in Humans Via Locally Generated Immunoreactive Insulin-Like Growth Factor I
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3260 - 3267.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Goya, A. de la Puente, S. Ramos, M. A. Martin, F. Escriva, and A. M. Pascual-Leone
Regulation of Insulin-like Growth Factor-I and -II by Glucose in Primary Cultures of Fetal Rat Hepatocytes
J. Biol. Chem., August 27, 1999; 274(35): 24633 - 24640.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Shaarawy, M. A. Fikry, B. A. Massoud, and S. Lotfy
Insulin-Like Growth Factor Binding Protein-3: A Novel Biomarker for the Assessment of the Synthetic Capacity of Hepatocytes in Liver Cirrhosis
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3316 - 3319.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-X. Zhuang, L. Wuarin, Z.-J. Fei, and D. N. Ishii
Insulin-Like Growth Factor (IGF) Gene Expression Is Reduced in Neural Tissues and Liver from Rats with Non-Insulin-Dependent Diabetes Mellitus, and IGF Treatment Ameliorates Diabetic Neuropathy
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 366 - 374.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Barreca, D. Larizza, G. Damonte, M. Arvigo, P. Ponzani, A. Cesarone, F. Lo Curto, F. Severi, G. Giordano, and F. Minuto
Insulin-Like Growth Factors (IGF-I and IGF-II) and IGF-Binding Protein-3 Production by Fibroblasts of Patients with Turner's Syndrome in Culture
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
V. Han, A. D'Ercole, and P. Lund
Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus
Science, April 10, 1987; 236(4798): 193 - 197.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society